Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing.
Angiogenesis is indispensable during fracture repair, and vascular endothelial growth factor (VEGF) is critical in this process. CCN1 (CYR61) is an extracellular matrix signaling molecule that has been implicated in neovascularization through its interactions with several endothelial integrin receptors. CCN1 has been shown to be up-regulated during the reparative phase of fracture healing; however, the role of CCN1 therein remains unclear. Here, the regulation of CCN1 expression in osteoblasts and the functional consequences thereof were studied. Stimulation of osteoblasts with VEGF resulted in a dose- and time-dependent up-regulation of CCN1 mRNA and protein. An up-regulation of both cell surface-associated CCN1 as well as extracellular matrix-associated CCN1 in osteoblasts was found. The supernatant of VEGF-prestimulated osteoblasts was chemotactic for endothelial cells, increasing their migration and stimulated capillary-like sprout formation. These effects could be attributed to the presence of CCN1 in the osteoblast supernatant as they were prevented by an antibody against CCN1 or by small interfering RNA-mediated knockdown of osteoblast CCN1. Moreover, the supernatant of VEGF-prestimulated osteoblasts induced angiogenesis in Matrigel plugs in vivo in a CCN1-dependent manner. In addition, blockade of CCN1 prevented bone fracture healing in mice. Taken together, the present work demonstrates a potential paracrine loop consisting of the VEGF-mediated up-regulation of CCN1 in osteoblasts that attracts endothelial cells and promotes angiogenesis. Such a loop could be operative during fracture healing.
Athanasopoulos
Athanasios N
AN
Department of Internal Medicine I, University Heidelberg, D-69120 Heidelberg.
Schneider
Darius
D
Department of Internal Medicine I, University Heidelberg, D-69120 Heidelberg.
Keiper
Tanja
T
Department of Internal Medicine I, University Heidelberg, D-69120 Heidelberg.
Alt
Volker
V
Department of Trauma Surgery, University Hospital Giessen-Marburg, D-35385 Giessen, Germany.
Pendurthi
Usha R
UR
Biomedical Research Division, The University of Texas Health Center at Tyler, Tyler, Texas.
Liegibel
Ute M
UM
Department of Internal Medicine I, University Heidelberg, D-69120 Heidelberg.
Sommer
Ulrike
U
Department of Internal Medicine I, University Heidelberg, D-69120 Heidelberg.
Nawroth
Peter P
PP
Department of Internal Medicine I, University Heidelberg, D-69120 Heidelberg.
Kasperk
Christian
C
Department of Internal Medicine I, University Heidelberg, D-69120 Heidelberg.
Chavakis
Triantafyllos
T
Department of Internal Medicine I, University Heidelberg, D-69120 Heidelberg; Experimental Immunology Branch (EIB), NCI, National Institutes of Health, Bethesda, Maryland 20992. Electronic address: chavakist@mail.nih.gov.
D002465:Cell Movement; D002478:Cells, Cultured; D055515:Cysteine-Rich Protein 61; D042783:Endothelial Cells / Q000502:physiology*; D017102:Fracture Healing; D006801:Humans; D017874:Immediate-Early Proteins / Q000235:genetics*; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics*; D018919:Neovascularization, Physiologic; D010006:Osteoblasts / Q000378:metabolism*; D015854:Up-Regulation; D042461:Vascular Endothelial Growth Factor A / Q000494:pharmacology*
C501848:CCN1 protein, human; D055515:Cysteine-Rich Protein 61; D017874:Immediate-Early Proteins; D036341:Intercellular Signaling Peptides and Proteins; D042461:Vascular Endothelial Growth Factor A